PT99532A - Processo de caracterizacao de um defeito de agregacao de plaquetas - Google Patents

Processo de caracterizacao de um defeito de agregacao de plaquetas

Info

Publication number
PT99532A
PT99532A PT99532A PT9953291A PT99532A PT 99532 A PT99532 A PT 99532A PT 99532 A PT99532 A PT 99532A PT 9953291 A PT9953291 A PT 9953291A PT 99532 A PT99532 A PT 99532A
Authority
PT
Portugal
Prior art keywords
defects
defect
plateling
characterization process
activation
Prior art date
Application number
PT99532A
Other languages
English (en)
Other versions
PT99532B (pt
Inventor
Mark H Ginsberg
Original Assignee
Scripps Clinic Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Research Inst filed Critical Scripps Clinic Research Inst
Publication of PT99532A publication Critical patent/PT99532A/pt
Publication of PT99532B publication Critical patent/PT99532B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Laminated Bodies (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT99532A 1990-11-15 1991-11-15 Processo de caracterizacao de um defeito de agregacao de plaquetas PT99532B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/614,723 US5196309A (en) 1990-11-15 1990-11-15 Characterization of platelet aggregation disorders

Publications (2)

Publication Number Publication Date
PT99532A true PT99532A (pt) 1992-09-30
PT99532B PT99532B (pt) 1999-04-30

Family

ID=24462455

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99532A PT99532B (pt) 1990-11-15 1991-11-15 Processo de caracterizacao de um defeito de agregacao de plaquetas

Country Status (13)

Country Link
US (2) US5196309A (pt)
EP (1) EP0557451B1 (pt)
JP (1) JP3186765B2 (pt)
AT (1) ATE163481T1 (pt)
AU (1) AU650312B2 (pt)
CA (1) CA2096230C (pt)
DE (1) DE69128966T2 (pt)
DK (1) DK0557451T3 (pt)
ES (1) ES2112310T3 (pt)
GR (1) GR3026510T3 (pt)
IE (1) IE62627B1 (pt)
PT (1) PT99532B (pt)
WO (1) WO1992008982A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427913A (en) * 1992-12-03 1995-06-27 Alberta Cancer Board Methods for determining platelet function
US5763199A (en) * 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay
US5561047A (en) * 1994-12-13 1996-10-01 The Trustees Of The University Of Pennsylvania Method of identifying effectors of integrin activation
US6521211B1 (en) * 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6139819A (en) 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
GB9519667D0 (en) * 1995-09-27 1995-11-29 Univ Manchester Pharmaceutical composition
DE69831229T2 (de) * 1997-05-14 2006-04-13 Biosite Diagnostics Inc., San Diego Schnelle bestimmung des verhältnisses von biologischen molekülen
WO1998053320A1 (en) * 1997-05-20 1998-11-26 The Johns Hopkins University A novel thrombopoietin signaling defect in polycythemia vera platelets
FR2764388B1 (fr) * 1997-06-06 1999-08-27 Biocytex Nouvelle methode d'analyse des recepteurs plaquettaires gpiib/iiia
US6210904B1 (en) 1997-10-14 2001-04-03 Merck & Co., Inc. Anticoagulant test
US6040182A (en) * 1997-11-12 2000-03-21 Becton Dickinson And Company Method and materials for efficiency protein immobilization on tissue culture treated assay plates
US6063584A (en) * 1997-11-21 2000-05-16 Merck & Co., Inc. Anticoagulant test
US20030003515A1 (en) * 2000-12-05 2003-01-02 Farrell David H. Monocloral antibody-based diagnostic assay for gamma fibrinogen
US20040131500A1 (en) * 2002-01-18 2004-07-08 Chow Herbert S. Device and method for evaluating platelets
ATE536889T1 (de) 2003-07-08 2011-12-15 Accumetrics Inc Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
JP2010261790A (ja) * 2009-05-01 2010-11-18 Takemichi Kanazawa 血管障害の素因の検査方法、及び治療法の選択方法
WO2015138916A1 (en) * 2014-03-14 2015-09-17 Yves Claude Nicolau Myo-inositol trispyrophoshate as an anti-diabetic agent
CN107429498B (zh) * 2015-01-14 2020-11-17 索林·迪努 用于以预定的尺寸整平砂和用于在污水通道中安装管道的鲁棒装置
CN111033256B (zh) * 2017-09-05 2022-07-12 深圳迈瑞生物医疗电子股份有限公司 血小板聚集样本的报警方法、血细胞分析仪及存储介质

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783330A (en) * 1984-11-15 1988-11-08 New England Medical Center Hospitals, Inc. Monoclonal antibodies to activated platelets
US4820505A (en) * 1985-04-04 1989-04-11 Scripps Clinic And Research Foundation Detection of activated platelets with antibodies to thrombospondin
US5114842A (en) * 1987-07-08 1992-05-19 The Scripps Research Institute Peptides and antibodies that inhibit platelet adhesion

Also Published As

Publication number Publication date
CA2096230C (en) 2003-05-27
US5656442A (en) 1997-08-12
JP3186765B2 (ja) 2001-07-11
AU9082491A (en) 1992-06-11
DE69128966T2 (de) 1998-06-18
PT99532B (pt) 1999-04-30
WO1992008982A1 (en) 1992-05-29
EP0557451A1 (en) 1993-09-01
IE62627B1 (en) 1995-02-22
DE69128966D1 (de) 1998-04-02
CA2096230A1 (en) 1992-05-16
AU650312B2 (en) 1994-06-16
EP0557451A4 (en) 1994-06-01
GR3026510T3 (en) 1998-07-31
EP0557451B1 (en) 1998-02-25
ATE163481T1 (de) 1998-03-15
DK0557451T3 (da) 1998-09-23
ES2112310T3 (es) 1998-04-01
JPH06504842A (ja) 1994-06-02
IE913975A1 (en) 1992-05-20
US5196309A (en) 1993-03-23

Similar Documents

Publication Publication Date Title
PT99532A (pt) Processo de caracterizacao de um defeito de agregacao de plaquetas
Brandtzaeg The increasing power of immunohistochemistry and immunocytochemistry
ATE128183T1 (de) Peptide und antikörper, die die bindung von blutplättchen verhindern.
ATE153701T1 (de) Immunchromatographischer assay und verfahren zur nutzung desselben
DE69126142D1 (de) Verbessertes bestimmungsverfahren für liganden
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
MY109045A (en) Mammalian receptors for interleukin 10 (il-10)
ATE98773T1 (de) Verfahren zur optischen analyse.
ATE410687T1 (de) Vorrichtung und verfahren zur simultanen durchführung von blutgruppenbestimmung, serumgegenprobe und antikörpersuch-test
DE69029336D1 (de) Interzellulares Adhäsions-Molekül-2 und seine Bindungsliganden
FI905725L (fi) Reagenssi ja sitä käyttävä menetelmä vähintään yhden leukosyyttialapopulaation määrittämiseksi kokoverestä automaattisella virtaussolulaskennalla
DE69637909D1 (de) ANTI-Fas-LIGAND ANTIKÖRPER UND TESTMETHODE UNTER VERWENDUNG DERSELBEN
DE59508474D1 (de) RHEUMAFAKTOR-ENTSTÖRUNG MIT ANTI-Fd-ANTIKÖRPERN
Chuang et al. Useful Panel of Antibodies for the Classification of Acute Leukemia by lmmunohistochemical Methods in Bone Marrow Trephine Biopsy Specimens
DE69001972D1 (de) Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.
RU2000114841A (ru) Антитела против фосфорилированного vasp (стимулированного вазодилататором фосфопротеина), гибридомные клетки для их получения и их применение
DE69032112D1 (de) Verfahren zur Isolierung von fetalen Zytotrophoblastzellen
NO163920C (no) Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.
ES8501630A1 (es) Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo.
ATE121788T1 (de) Blutgerinnungsfaktor beta xiia monoklonale antikörper und immunanalyse.
DE69606651D1 (de) Test zur diagnose von demenz
ES2177547T3 (es) Metodo gradual para detectar la enfermedad de chagas y reactivos utilizados en tales efectos.
ATE180495T1 (de) Unterscheidung von htlv-i und htlv-ii unter verwendung von synthetischen peptiden
DE3785175D1 (de) A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung.
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920525

FG3A Patent granted, date of granting

Effective date: 19990128

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20100728